Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2500019	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2025-01-17		Catalent Cts LLC;Rigel Pharmaceuticals Inc			view
CYHS2401036	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(4)	Generic Drug	2024-04-09		Asymchem Life Science (Tianjin) Co Ltd;Cornerstone Pharmaceutical (Suzhou) Co Ltd			view
JYHB2400073	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2024-02-06		Catalent Cts LLC;Genentech Inc			view
JYHB2300685	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2023-11-23		Catalent Cts LLC;Genentech Inc			view
JXHS2200094	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(5.1)	Import Drug Application	2022-10-13		Catalent Cts LLC;GenePharm Inc;Cornerstone Pharmaceutical (Suzhou) Co Ltd			view
JYHB2200443	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2022-08-15		Catalent Cts LLC;Genentech Inc			view
JYHB2200344	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Supplementary Application	2022-07-07		Catalent Cts LLC;Genentech Inc			view
JXHS2101001	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(5.1)	Import Drug Application	2021-03-29		Catalent Cts LLC;Blueprint Medicines Corp;Cornerstone Pharmaceutical (Suzhou) Co Ltd			view
JXHS2000131	普拉替尼胶囊	pralsetinib	Capsule	Chemical Drugs(1)	Import Drug Application	2020-09-08	基石药业（苏州）有限公司	Cornerstone Pharmaceutical (Suzhou) Co Ltd;Catalent Cts LLC;Blueprint Medicines Corp	Certificate Issued	2021-03-25	view